Yüklüyor......
Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma
Application of advances in genomic and proteomic technologies has provided molecular insights into distinct types of aggressive B- and T-cell non-Hodgkin's lymphomas (NHLs). This has led to the validation of novel biomarkers of classification, risk-stratification, and druggable targets. The pro...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Clinical Oncology
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138544/ https://ncbi.nlm.nih.gov/pubmed/21483007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.7171 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|